Group A received an in situ tissue-engineered graft containing @ @ CD@ + cells/mL along with @ @ CD@ + , CD@ + , and CD@ + cells/mL together with rhBMP-@ in an absorbable collagen sponge ( @ mg/cm of defect ) and crushed cancellous allogeneic bone .